|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400088967 |
|
最近更新日期: Date of Last Refreshed on: |
2024-08-29 15:45:13 |
|
注册时间: Date of Registration: |
2024-08-29 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
听乐治疗对脑卒中患者平衡功能的影响 |
|
Public title: |
Effect of Therapeutic Listening on balance function in stroke patients |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
听乐治疗对脑卒中患者平衡功能的影响 |
|
Scientific title: |
Effect of Therapeutic Listening on balance function in stroke patients |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈锐瑾 |
研究负责人: |
陈锐瑾 |
|
Applicant: |
Ruijin Chen |
Study leader: |
Ruijin Chen |
|
申请注册联系人电话: Applicant telephone: |
+86 153 6842 6733 |
研究负责人电话: Study leader's telephone: |
+86 153 6842 6733 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
749898023@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
749898023@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国云南省昆明市五华区滇缅大道374号 |
研究负责人通讯地址: |
中国云南省昆明市五华区滇缅大道374号 |
|
Applicant address: |
374 Dianmian Avenue, Kunming, Yunnan, China |
Study leader's address: |
374 Dianmian Avenue, Kunming, Yunnan, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
昆明医科大学第二附属医院 |
||
|
Applicant's institution: |
The Second Affiliated Hospital of Kunming Medical University |
||
|
研究负责人所在单位: |
昆明医科大学第二附属医院 |
||
|
Affiliation of the Leader: |
The Second Affiliated Hospital of Kunming Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
审-PJ-科-2023-189 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
昆明医科大学第二附属医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of The Second Affiliated Hospital of Kunming Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-08-21 00:00:00 |
||
|
伦理委员会联系人: |
舒钧 |
||
|
Contact Name of the ethic committee: |
Jun Shu |
||
|
伦理委员会联系地址: |
中国云南省昆明市五华区滇缅大道374号 |
||
|
Contact Address of the ethic committee: |
374 Dianmian Avenue, Kunming, Yunnan, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 871 6340 2346 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
昆明医科大学第二附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Second Affiliated Hospital of Kunming Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国云南省昆明市五华区滇缅大道374号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
374 Dianmian Avenue, Kunming, Yunnan, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
昆明医科大学第二附属医院康复医学部现有设备 |
||||||||||||||||||||||
|
Source(s) of funding: |
Existing equipment of Rehabilitation Medicine Department of The Second Affiliated Hospital of Kunming Medical University |
||||||||||||||||||||||
|
Target disease: |
stroke |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
(1)明确听乐治疗(专辑引力葡萄)治疗对脑卒中患者平衡功能的影响,并确立该方法在卒中康复治疗中的应用价值。 (2)揭示卒中康复过程中,平衡功能与日常生活自理能力的相互影响关系,为卒中康复策略的抉择提供新思路与借鉴。 |
||||||||||||||||||||||
|
Objectives of Study: |
(1) To clarify the effect of Therapeutic Listening(Gravity Grape) on the balance function of stroke patients, and to establish the application value of this method in stroke rehabilitation. (2) To reveal the interaction between balance function and self-care ability of daily life in the process of stroke rehabilitation, providing new ideas and references for the choice of stroke rehabilitation strategies. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1)患者均符合第4届全国脑血管病学术会议研究制定的脑卒中诊断标准;均经CT或MRI检查确诊为脑出血或脑梗死; 2)年龄18-80岁,性别不限; 3)偏瘫或者四肢瘫; 4)股四头肌、臀大肌、小腿三头肌MMT大于3级; 5)MMSE大于等于24分; 6)Berg平衡量表21-40分; 7)患者或家属知情同意并签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
1) All patients met the diagnostic criteria for stroke formulated by the 4th National Conference on Cerebrovascular Diseases; All patients were diagnosed with cerebral hemorrhage or cerebral infarction by CT or MRI. 2) Age 18-80 years old, gender unlimited; 3) hemiplegia or quadriplegia; 4) MMT of quadriceps, gluteus maximus and triceps crus is greater than grade 3; 5) MMSE is greater than or equal to 24 points; 6) Berg Balance Scale 21-40 points; 7) Patients or family members give informed consent and sign informed consent. |
||||||||||||||||||||||
|
排除标准: |
1)不符合上述诊断标准和纳入标准者; 2)存在脑卒中以外的其他神经系统疾病; 3)MMSE量表<24分; 4)患有听觉诱发癫痫; 5)合并重要器官功能障碍或者其他严重躯体疾病; 6)存在精神障碍; 7)拒绝参与实验或者签署知情同意书; |
||||||||||||||||||||||
|
Exclusion criteria: |
1) Those who do not meet the above diagnostic criteria and inclusion criteria; 2) The presence of other neurological diseases other than stroke; 3) MMSE scale < 24 points; 4) Suffering from auditory induced epilepsy; 5) Combined with vital organ dysfunction or other serious physical diseases; 6) There are mental disorders; 7) Refuse to participate in the experiment or sign the informed consent; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-08-21 00:00:00至 To 2024-08-21 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2023-10-14 00:00:00 至 To 2024-08-21 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由研究实施者准备30只信封,选择脑梗死患者 30 例,按照信封法将患者随机分为两组:①普通白噪音+常规康复组; ②听乐治疗+常规康复组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Thirty patients with cerebral infarction were randomly divided into two groups according to envelope method: (1) general white noise + routine rehabilitation group; ②Therapeutic Listening(Gravity Grape) + routine rehabilitation group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
单盲法,治疗师知晓,患者不知晓 |
|
Blinding: |
Single blind. Therapist knows, patient doesn't |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
Resman系统(http://www.medresman.org.cn/login.aspx) |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
http://www.medresman.org.cn/login.aspx |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集采用纸质量表,电子采集和管理系统使用Resman系统进行管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Paper scale was used for data collection, and Resman system was used for electronic collection and management. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |